Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
S-phase kinase-associated protein 1 pseudogene 2 (SKP1P2) is a non-protein-coding pseudogene in the human genome, so-named due to its sequence similarity to the functional SKP1 gene, which is a component of the SCF ubiquitin ligase complex involved in cell cycle progression and protein degradation. SKP1P2, also referred to as SKP1B or p19B, does not encode a functional protein and is not considered a therapeutic target or biomarker. While some pseudogenes have regulatory RNA functions in certain biological contexts (e.g., through small interfering RNAs), SKP1P2’s specific function, expression profile, and clinical relevance remain undefined[3][5][7][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on S-phase kinase-associated protein 1 pseudogene 2 (SKP1P2).